SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001013762-13-001036
Filing Date
2013-08-12
Accepted
2013-08-12 11:54:51
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 DELMAR PHARMACEUTICALS, INC. FORM 10-Q form10q.htm 10-Q 1107875
2 EXHIBIT 31.1 ex311.htm EX-31.1 16385
3 EXHIBIT 31.2 ex312.htm EX-31.2 15733
4 EXHIBIT 32.1 ex321.htm EX-32.1 5808
5 EXHIBIT 32.2 ex322.htm EX-32.2 6069
  Complete submission text file 0001013762-13-001036.txt   7835913

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dmpi-20130630.xml EX-101.INS 675169
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dmpi-20130630.xsd EX-101.SCH 61959
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmpi-20130630_cal.xml EX-101.CAL 29317
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmpi-20130630_def.xml EX-101.DEF 209044
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE dmpi-20130630_lab.xml EX-101.LAB 433299
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmpi-20130630_pre.xml EX-101.PRE 319917
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54801 | Film No.: 131028890
SIC: 2834 Pharmaceutical Preparations